This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

OptionsXpress, Rite Aid: Small-Cap Winners

Stocks in this article: OXPSLEAPVRGYYRCWRADCRISDNN

NEW YORK ( TheStreet) -- Small-caps were soaring Monday after a renewal in deal activity spurred stocks. Shares of OptionsXpress (OXPS) were climbing 15% to $17.69 after Charles Schwab (SCHW) said it will buy the online retail brokerage in an all-stock transaction worth $1 billion.

Shareholders will be offered 1.02 shares of Schwab's stock for every share held, valuing OptionsExpress at $17.91 per share.

Shares of Leap Wireless (LEAP) were leaping 12% to $13.64 on the back of heightened deal buzz following the AT&T (T) - T-Mobile deal announced over the weekend. Speculation that Sprint Nextel (S) might gobble up smaller players to compete with the merged entity was driving the stock.

Verigy (VRGY), a manufacturer of semiconductor testing equipment, was ahead by 9.6% at $13.98 after it said that a $908 million offer it received from Japan's Advantest was superior to a pending deal with LTX-Credence.

Globalstar (GSAT), a provider of mobile, satellite voice and data services, was among the biggest gainers Monday, after the FCC (Federal Communications Committee) granted it the authority to operate second generation satellites within the United States. The stock was gaining nearly 30% to $1.35 per share.

Shares of YRC Worldwide (YRCW) were attracting unusual interest, surging 13.5% to $2.13 on volumes more than double its three-month average. The trucking company warned last week that it failed to get pension funds to sign off on its restructuring plan, a move that will potentially prompt its lenders to rule that it is in default and force it into bankruptcy. Negotiations are still underway.

Rite Aid (RAD) was another stock gaining on unusual volume activity. Shares were up 8.6% at $1.06 per share.

Shares of drug maker Curis (CRIS) were gaining after it announced that a mid-stage trial of a skin-cancer treatment it is studying with Roche's Genentech unit had been successful in shrinking tumors. The stock was climbing 11.6% to $3.27.

Uranium mining company Denison Mines (DNN) was gaining after it announced an increase in the resource estimate of its Hairhan deposit in Mongolia. Uranium contained in the Indicated Resources increased 151% and in Inferred Resources increased 67% over the resources reported previously. The stock had been under pressure over concerns about the nuclear power plant crisis in Japan.

--Written by Shanthi Bharatwaj in New York



>To contact the writer of this article, click here: Shanthi Bharatwaj.

>To follow the writer on Twitter, go to http://twitter.com/shavenk.

>To submit a news tip, send an email to: tips@thestreet.com.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,814.94 -2.96 -0.02%
S&P 500 2,067.03 -2.38 -0.12%
NASDAQ 4,758.2520 +3.36 0.07%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs